Consultant, Malaria Clinical Team
Being a leading international tropical medicine and public health expert and globally recognized, especially for research achievements on malaria, snakebite and poisoning, I was a collaborator with MORU for about two decades working in diverse fields primarily on malaria. I was the Co-Chair of the WHO Snakebite Envenoming Working Group, the President of the Toxicology Society of Bangladesh (TSB), the National Coordinator of a number of multi-partner collaborative research projects, the Bangladesh Principal Investigator of multicentre study to see the effectiveness of combination antimalarials (TRAC I, II & DeTACT), supervise and mentor the MORU led research at Chattogram Medical College Hospital, Bangladesh
I worked in different capacities in Bangladesh since 1978, obtained PhD from the University of Newcastle upon Tyne, UK, in 1993. During long career I held positions as Professor of Medicine, Director General, the Principal of Dhaka Medical College, and Dean of the Faculty of Medicine, University of Dhaka, Bangladesh.
Experience of conducting multi-country collaborative research especially on malaria, snakebite envenoming, Kala azar and other neglected tropical diseases that globally changed public awareness, health policy and clinical management. With the support of WHO/TDR, Mahidol Oxford Research Unit, Bangkok, Thailand, Wellcome Trust of the United Kingdom, Drugs for Neglected Diseases Initiative (DNDi) and Grand Challenges Canada (Saving Brains).
My recent research projects include the Artesunate Suppository Severe Malaria Cohort (SBASSMC), Practice of VENTilation in Critically Ill Patients in Middle–Income Countries (PRoVENT–iMIC) and the FlutNetz project.
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42
Mapping the travel patterns of people with malaria in Bangladesh
Sinha I. et al, (2020), BMC Medicine, 18
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
van der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360
Associations Between Restrictive Fluid Management and Renal Function and Tissue Perfusion in Adults With Severe Falciparum Malaria: A Prospective Observational Study
Ishioka H. et al, (2020), The Journal of Infectious Diseases, 221, 285 - 292
Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis
(2019), BMC Medicine, 17